Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park

Form 483 issued September 6, 2019 · Jadcherla, India

Inspection
Aug 29 – Sep 6, 2019
Investigator
Roger F. Zabinski
Observations
2
Pages
3
FEI number
3009876430

In short: On September 6, 2019, FDA issued a Form 483 with 2 observations to Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park in Jadcherla, Telangana (FEI 3009876430) after an inspection that ran Aug 29 – Sep 6, 2019. The investigator was Roger F. Zabinski. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.166 (stability testing).

At a glance

2 of 2 observations on this 483 concern laboratory controls.

Laboratory controls2

Most cited: 21 CFR 211.166(a) (1×) · 211.160(b)(4) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The written stability testing…

  2. 02

    The use of instruments and apparatus not meeting…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park?

FDA listed 2 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.166 (stability testing). The opening words of each observation are shown on this page.

Who inspected Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park?

Roger F. Zabinski is named on this Form 483, for the inspection of Aug 29 – Sep 6, 2019. Each investigator has a profile showing what they cite most.

When was Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park inspected by FDA?

The inspection ran Aug 29 – Sep 6, 2019, and the Form 483 is dated September 6, 2019.

How do I get the full Form 483 for Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free